1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow GI-108: new trials by email Literature Review of GI-108 trials Research Report on GI-108
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors GI-108 - Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | Recruiting | GI Innovation, Inc. | 102 | 2025-04-22 | 2026-09-17 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
South Korea (1)